Literature DB >> 15920473

Exo84 and Sec5 are competitive regulatory Sec6/8 effectors to the RalA GTPase.

Rongsheng Jin1, Jagath R Junutula, Hugo T Matern, Karen E Ervin, Richard H Scheller, Axel T Brunger.   

Abstract

The Sec6/8 complex, also known as the exocyst complex, is an octameric protein complex that has been implicated in tethering of secretory vesicles to specific regions on the plasma membrane. Two subunits of the Sec6/8 complex, Exo84 and Sec5, have recently been shown to be effector targets for active Ral GTPases. However, the mechanism by which Ral proteins regulate the Sec6/8 activities remains unclear. Here, we present the crystal structure of the Ral-binding domain of Exo84 in complex with active RalA. The structure reveals that the Exo84 Ral-binding domain adopts a pleckstrin homology domain fold, and that RalA interacts with Exo84 via an extended interface that includes both switch regions. Key residues of Exo84 and RalA were found that determine the specificity of the complex interactions; these interactions were confirmed by mutagenesis binding studies. Structural and biochemical data show that Exo84 and Sec5 competitively bind to active RalA. Taken together, these results further strengthen the proposed role of RalA-regulated assembly of the Sec6/8 complex.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920473      PMCID: PMC1150893          DOI: 10.1038/sj.emboj.7600699

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  Experimental assessment of differences between related protein crystal structures.

Authors:  G J Kleywegt
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-11

Review 2.  Membrane fusion and exocytosis.

Authors:  R Jahn; T C Südhof
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

3.  The exocyst complex associates with microtubules to mediate vesicle targeting and neurite outgrowth.

Authors:  I E Vega; S C Hsu
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

4.  Effector recognition by the small GTP-binding proteins Ras and Ral.

Authors:  B Bauer; G Mirey; I R Vetter; J A García-Ranea; A Valencia; A Wittinghofer; J H Camonis; R H Cool
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

5.  Exo84p is an exocyst protein essential for secretion.

Authors:  W Guo; A Grant; P Novick
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

6.  The Sec6/8 complex in mammalian cells: characterization of mammalian Sec3, subunit interactions, and expression of subunits in polarized cells.

Authors:  H T Matern; C Yeaman; W J Nelson; R H Scheller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

7.  Structural basis for discrimination of 3-phosphoinositides by pleckstrin homology domains.

Authors:  K M Ferguson; J M Kavran; V G Sankaran; E Fournier; S J Isakoff; E Y Skolnik; M A Lemmon
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

Review 8.  Signal-dependent membrane targeting by pleckstrin homology (PH) domains.

Authors:  M A Lemmon; K M Ferguson
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

9.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

10.  Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma.

Authors:  M E Pacold; S Suire; O Perisic; S Lara-Gonzalez; C T Davis; E H Walker; P T Hawkins; L Stephens; J F Eccleston; R L Williams
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

View more
  64 in total

Review 1.  The exocyst complex in exocytosis and cell migration.

Authors:  Jianglan Liu; Wei Guo
Journal:  Protoplasma       Date:  2011-10-14       Impact factor: 3.356

2.  RalA and RalB proteins are ubiquitinated GTPases, and ubiquitinated RalA increases lipid raft exposure at the plasma membrane.

Authors:  Vincent Neyraud; Vasily N Aushev; Anastassia Hatzoglou; Brigitte Meunier; Ilaria Cascone; Jacques Camonis
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

3.  Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients.

Authors:  Jon A Kenniston; Mark A Lemmon
Journal:  EMBO J       Date:  2010-08-10       Impact factor: 11.598

Review 4.  The Exocyst at a Glance.

Authors:  Bin Wu; Wei Guo
Journal:  J Cell Sci       Date:  2015-08-03       Impact factor: 5.285

5.  Ral GTPase and the exocyst regulate autophagy in a tissue-specific manner.

Authors:  Kirsten Tracy; Panagiotis D Velentzas; Eric H Baehrecke
Journal:  EMBO Rep       Date:  2015-11-23       Impact factor: 8.807

6.  Identification of Rab11 as a small GTPase binding protein for the Evi5 oncogene.

Authors:  Christopher J Westlake; Jagath R Junutula; Glenn C Simon; Manohar Pilli; Rytis Prekeris; Richard H Scheller; Peter K Jackson; Adam G Eldridge
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-17       Impact factor: 11.205

Review 7.  Regulation of Cell Polarity by Exocyst-Mediated Trafficking.

Authors:  Noemi Polgar; Ben Fogelgren
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

8.  Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.

Authors:  Samuel C Falsetti; De-an Wang; Hairuo Peng; Dora Carrico; Adrienne D Cox; Channing J Der; Andrew D Hamilton; Saïd M Sebti
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

Review 9.  Regulation of membrane trafficking in polarized epithelial cells.

Authors:  Heike Fölsch
Journal:  Curr Opin Cell Biol       Date:  2008-02-20       Impact factor: 8.382

10.  RAP-1 and the RAL-1/exocyst pathway coordinate hypodermal cell organization in Caenorhabditis elegans.

Authors:  Ester W Frische; Wendy Pellis-van Berkel; Gijs van Haaften; Edwin Cuppen; Ronald H A Plasterk; Marcel Tijsterman; Johannes L Bos; Fried J T Zwartkruis
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.